Life Science trends and analysis 1st half 2024

Dr. Courtney Young, co- founder and CEO of MyoGene Bio.

Dr. Courtney Young is a prominent figure in the field of biotechnology, known for her pioneering work in gene editing therapies for rare muscle diseases. She is the co-founder and CEO of MyoGene Bio, a biotech startup focused on developing CRISPR-based therapies, particularly for Duchenne Muscular Dystrophy (DMD), a severegenetic disorder with no current cure.

Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc.

Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc., a biotechnology company developing innovative gene therapies for chronic pain and other conditions.

Dr. Lu Yin CEO of Persperion Diagnostics

Exploring the Future of Personal Diagnostics with Dr. Lu Yin of Persperion Diagnostics

Survive to 25' - The Life Science Ecosystem

Bob McGriff and David Crean discuss the current conditions in Life Science industry financing and what to look for in the second half of 2024.

Life Science trends and analysis 1st half 2024

On this episode of the podcast Bob and David discuss the current state of the life science ecosystem through the halfway point of 2024, and they offer thoughts and analysis of what to expect for the remainder of this year.